European Immunization Agenda 2030: draft for the Seventy-first Regional Committee for Europe

Overview

This Draft document is prepared for the Seventy-first Regional Committee for Europe. The European Immunization Agenda 2030 (EIA2030), a vision and strategy crafted by Member Statesfor achieving the full benefits of immunization in the WHO European Region for the next decade,builds on the achievements and lessons learned from implementation of the European Vaccine Action Plan 2015–2020 (EVAP). Implementation of EVAP saw many successes – such as sustained polio-free status in the Region, an increased number of Member States verified as having eliminated measles and rubella, progress with documenting hepatitis B control, improved vaccine introduction decision-making through national immunization technical advisory groups, and most Member States achieving financial self-sufficiency for vaccine procurement. EIA2030 outlines the strategic pivots required to achieve its vision, and considers key contextual challenges to be addressed, such as the complexities of sustaining high and equitable coverage, specific challenges faced by middle-income countries in the Region, and gaps in immunization over the past years that could fuel future outbreaks. EIA2030 provides the vision and framework for action by WHO, policy-makers, national immunization programmes, professional associations, civil society,community-based organizations and other immunization stakeholders for the next decade in the Region. EIA2030 is one of the flagship initiatives of the European Programme of Work 2020–2025 –“United Action for Better Health in Europe”, which was adopted by the WHO Regional Committee for Europe in September 2020. EIA2030 was developed at the request of Member States through a truly bottom-up consultative and iterative process with the various regional stakeholders. Its regional focus areas were determined by national priorities and reaffirmed through multi-stakeholder consultations.